About Beijing Leadman Biochemistry
Beijing Leadman Biochemistry is a company based in Beijing (China) founded in 1997. The company has 468 employees as of December 31, 2024. Beijing Leadman Biochemistry has completed 1 acquisition, including DiaSys Diagnostic Systems.
- Headquarter Beijing, China
- Employees 468 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Beijing Leadman Biochemistry Co., Ltd. Class A
-
Annual Revenue
$49.26 M (USD)-20.06as on Dec 31, 2024
-
Net Profit
-$10.29 M (USD)-589.66as on Dec 31, 2024
-
EBITDA
$3.01 M (USD)-73.2as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
468
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Beijing Leadman Biochemistry
Beijing Leadman Biochemistry is a publicly listed company on the SZSE with ticker symbol 300289 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Beijing Leadman Biochemistry
Detailed funding history for Beijing Leadman Biochemistry
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Beijing Leadman Biochemistry
Beijing Leadman Biochemistry has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include DiaSys Diagnostic Systems.
Investment portfolio details for Beijing Leadman Biochemistry
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of instruments, reagents and kits for the life science industry
|
Locked | Locked | 1991 | Locked |
Complete acquisition details for Beijing Leadman Biochemistry
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Beijing Leadman Biochemistry
Detailed financials for Beijing Leadman Biochemistry
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Beijing Leadman Biochemistry Comparisons
Peer comparison for Beijing Leadman Biochemistry
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Beijing Leadman Biochemistry
Detailed competitors of Beijing Leadman Biochemistry
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Beijing Leadman Biochemistry
Complete news archive for Beijing Leadman Biochemistry
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beijing Leadman Biochemistry
Beijing Leadman Biochemistry was founded in 1997.
Beijing Leadman Biochemistry is headquartered in Beijing, China.
Shen Guangqian is the current CEO of Beijing Leadman Biochemistry.
As of Dec 31, 2024, the latest employee count at Beijing Leadman Biochemistry is 468.
Annual revenue of Beijing Leadman Biochemistry is $49.26M as on Dec 31, 2024.
Beijing Leadman Biochemistry was established in 1997 in Beijing, China, within the biotechnology and medical devices sector. Operations focus on the production of in vitro diagnostic equipment, biochemical raw materials, and various medical instruments. The company maintains its domain at leadmanbio.com and is led by CEO Shen Guangqian. Activities are centered in China, supporting diagnostic and healthcare applications through these core manufacturing processes.
Yes, Beijing Leadman Biochemistry is publicly traded on SZSE under the ticker symbol 300289.
Beijing Leadman Biochemistry has made 1 acquisition, including DiaSys Diagnostic Systems.
The ticker symbol of Beijing Leadman Biochemistry is 300289 on SZSE.